Novavax CDC Vaccine Label

Novavax sees weak Covid vaccine sales

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales

Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of handing over the rights to sell the shot to French drugmaker Sanofi (SASY.PA), opens new tab.

GlobalData on MSN · 2d

FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine

The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.

The Business Journals · 2d

Novavax sees weak Covid vaccine sales, convinced Sanofi can do better

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals and a pipeline of new vaccines it's now evaluating for R&D.

Trump taps Robert F. Kennedy Jr., vaccine skeptic

Firstpost · 4h

Why vaccine stocks tumbled after Trump chose RFK Jr for US health secretary

The selection of vaccine sceptic Robert F Kennedy Jr by US President-elect Donald Trump to head the Department of Health and Human Services has sparked a market shock, with stocks of leading vaccine makers,

The Washington Post on MSN · 11h

Trump taps Robert F. Kennedy Jr., vaccine skeptic, to lead HHS

The nearly $2 trillion agency administers health-insurance programs for millions of Americans, approves medications and oversees vaccine safety.

U.S. News & World Report · 12h

Trump Picks Vaccine Skeptic Robert F. Kennedy Jr. to Lead Health & Human Services

In a move guaranteed to alarm many, President-elect Donald Trump has chosen Robert F. Kennedy Jr., a vocal opponent of vaccines and other tenets of mainstream health care, to head the massive U.S. Department of Health and Human Services (HHS).

Tennessean16d

Moderna, Pfizer or Novavax? How the three Covid-19 vaccines differ according to Yale Medicine

With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control ...

MarketWatch3d

Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update

Novavax can move forward with a trial for its combined Covid-19 and influenza vaccine after regulators lifted a clinical hold. The Gaithersburg, Md., vaccine developer said Monday that the U.S ...

Wall Street Journal29d

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines

Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and stand-alone flu inoculation, sending shares down sharply. The vaccine ...

Yahoo Finance3d

Novavax Gets FDA Approval To Resume Testing Two Vaccines After Clinical Hold

Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold. Regulators stopped testing last month ...

FiercePharma9d

Novavax coughs up $123.8M to settle COVID vaccine supply dispute with UK

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. The Maryland biotech has agreed to pay $123.8 million to end a COVID vaccine supply pact with the UK Health Security ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results